Harpoon Therapeutics, Inc. (HARP)
NASDAQ: HARP · IEX Real-Time Price · USD
0.703
+0.018 (2.66%)
Jun 2, 2023, 10:43 AM EDT - Market open
Harpoon Therapeutics Market Cap
Harpoon Therapeutics has a market cap or net worth of $26.13 million as of June 2, 2023. Its market cap has decreased by -63.09% in one year.
Market Cap
26.13M
Enterprise Value
-19.30M
1-Year Change
-63.09%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since February 8, 2019, Harpoon Therapeutics's market cap has decreased from $322.80M to $26.13M, a decrease of -91.91%. That is a compound annual growth rate of -44.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2023 | 25.60M | -1.16% |
May 30, 2023 | 25.90M | 4.86% |
May 26, 2023 | 24.70M | -7.84% |
May 25, 2023 | 26.80M | -3.60% |
May 24, 2023 | 27.80M | -3.81% |
May 23, 2023 | 28.90M | 0.70% |
May 22, 2023 | 28.70M | 1.77% |
May 19, 2023 | 28.20M | -6.00% |
May 18, 2023 | 30.00M | -1.64% |
May 17, 2023 | 30.50M | -0.97% |
May 16, 2023 | 30.80M | 9.22% |
May 15, 2023 | 28.20M | 1.44% |
May 12, 2023 | 27.80M | -9.74% |
May 11, 2023 | 30.80M | 3.36% |
May 10, 2023 | 29.80M | 9.16% |
May 9, 2023 | 27.30M | 7.06% |
May 8, 2023 | 25.50M | 0.79% |
May 5, 2023 | 25.30M | 10.00% |
May 4, 2023 | 23.00M | 11.65% |
May 3, 2023 | 20.60M | - |
May 2, 2023 | 20.60M | 0.98% |
May 1, 2023 | 20.40M | -6.85% |
Apr 28, 2023 | 21.90M | 4.29% |
Apr 27, 2023 | 21.00M | -2.33% |
Apr 26, 2023 | 21.50M | 0.47% |
View and export this data all the way back to 2019.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Revolution Medicines, Inc. | 2.66B |
Alector, Inc. | 611.80M |
Stoke Therapeutics, Inc. | 479.45M |
Adaptimmune Therapeutics plc | 178.96M |
Black Diamond Therapeutics, Inc. | 67.91M |
TCR2 Therapeutics Inc. | 61.64M |
Homology Medicines, Inc. | 56.07M |
Passage Bio, Inc. | 52.93M |
Atreca, Inc. | 41.51M |